It’s been a nightly ritual since Doris Winn was diagnosed with glaucoma four or five years ago: the administering of eye drops to reduce pressure inside the eye. It’s not a routine she’s particularly ...
Please provide your email address to receive an email when new articles are posted on . During a most unexpected and challenging year, ophthalmic practices are looking for reasons to celebrate. The ...
NASHVILLE, Tenn., Aug. 3, 2020 /PRNewswire-PRWeb/ -- Loden Vision Centers, a leading comprehensive ophthalmology company with 5 locations across the greater Nashville and surrounding areas, has ...
Please provide your email address to receive an email when new articles are posted on . The recent paradigm shift in the treatment of glaucoma moving toward earlier intervention, better managing ...
- DURYSTA™ lowered intraocular pressure in patients with open-angle glaucoma or ocular hypertension by approximately 30 percent from baseline in two Phase 3 studies - - Allergan continues five ongoing ...
Dr. Roman Krivochenitser, right, talks with patient Doris Winn, 81, after her procedure for a treatment called Durysta, in which a tiny pellet is injected into the eye that releases medication over a ...
DUBLIN, March 5, 2020 /PRNewswire/ -- Allergan plc (NYSE: AGN), a leading global pharmaceutical company with more than 70 years of heritage in eye care, today announced that the U.S. Food and Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results